Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab-Reference-Cited by-同舟云学术

Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab

Published:2019-01 Issue:1 Volume:143 Page:142-154
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Brunner Patrick M.,Pavel Ana B.,Khattri Saakshi,Leonard Alexandra,Malik Kunal,Rose Sharon,Jim On Shelbi,Vekaria Anjali S.,Traidl-Hoffmann Claudia,Singer Giselle K.,Baum Danielle,Gilleaudeau Patricia,Sullivan-Whalen Mary,Fuentes-Duculan Judilyn,Li Xuan,Zheng Xiuzhong,Estrada Yeriel,Garcet Sandra,Wen Huei-Chi,Gonzalez Juana,Coats Israel,Cueto Inna,Neumann Avidan U.,Lebwohl Mark G.,Krueger James G.,Guttman-Yassky Emma

Funder

National Institutes of Health

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Center for Advancing Translational Sciences

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference83 articles.

1. New insights into the epidemiology of childhood atopic dermatitis;Flohr;Allergy,2014

2. Atopic dermatitis;Weidinger;Lancet,2016

3. Public health burden and epidemiology of atopic dermatitis;Silverberg;Dermatol Clin,2017